Related Experiment Video
Updated: Jun 19, 2026
08:35
Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management
K Tziomalos1, V G Athyros, A Karagiannis
1Department of Clinical Biochemistry (Vascular Prevention Clinic), Royal Free Hospital Campus, University College Medical School, University College London (UCL), London, UK.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|October 17, 2009
Summary
Metabolic syndrome (MetS) involves central obesity, impaired glucose, dyslipidemia, and hypertension, increasing risks for type 2 diabetes and vascular events. Endothelial dysfunction is a key factor in MetS, impacting atherosclerosis and insulin resistance.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Metabolic Research
Background:
- Metabolic syndrome (MetS) is a cluster of conditions including central obesity, dyslipidemia, hypertension, and impaired glucose metabolism.
- MetS significantly elevates the risk for type 2 diabetes mellitus (T2DM) and adverse vascular events.
- Each component of MetS negatively impacts endothelial health, contributing to disease pathogenesis.
Purpose of the Study:
- To review the prevalence and underlying mechanisms of endothelial dysfunction in patients with MetS.
- To discuss the potential therapeutic benefits of lifestyle modifications and pharmacological treatments on endothelial function in MetS.
- To explore the clinical significance of improving endothelial function for reducing T2DM and vascular event risks.
Main Methods:
- Systematic literature review focusing on endothelial dysfunction in MetS.
- Analysis of studies investigating the impact of MetS components on endothelial function.
- Review of evidence on lifestyle and pharmacological interventions targeting endothelial function.
Main Results:
- Endothelial dysfunction is a common feature across all components of MetS.
- Dysfunctional endothelium plays a critical role in the development of atherosclerosis and insulin resistance.
- Lifestyle changes and certain medications may improve endothelial function in MetS patients.
Conclusions:
- Endothelial dysfunction is central to the pathophysiology of MetS, linking its components to T2DM and vascular complications.
- Further research is needed to confirm if enhancing endothelial function translates to reduced clinical risks in MetS.
- Targeting endothelial dysfunction represents a potential therapeutic strategy for managing MetS and its sequelae.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...